CGIX News and Press, Cancer Genetics Inc. From 08/25/20

Cancer Genetics (NASDAQ: CGIX ) -16% . More news on: Cancer Genetics, Inc., Smith & Wesson Brands, Inc., Sonnet BioTherapeutics Holdings, Inc., Stocks on the move, , Read more ...

NEW YORK , Aug. 25, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cancer Genetics, Inc. (NASDAQ: CGIX) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection ...

Point Roberts, WA and Delta, BC - August 24, 2020 (Investorideas.com Newswire) Investorideas.com, a leader in crypto and blockchain investing news brings you today's edition of the Crypto Corner podcast and commentary on what's driving cryptocurrency stocks and the crypto market. Listen to t...

Gainers:  Cancer Genetics (NASDAQ: CGIX ) +142% . More news on: Cancer Genetics, Inc., iBio, Inc., Sonnet BioTherapeutics Holdings, Inc., Stocks on the move, , Read more ...

Are These Biotech & COVID Penny Stocks On Your List Today? Over the weekend we saw some big interest grow in certain penny stocks after some Presidential remarks. U.S. President Donald Trump announced the EUA or emergency use authorization of convalescent plasma for COVID-19. At his pre...

Cancer Genetics (NASDAQ: CGIX )   surges 231%  after entering into a definitive merger agreement with privately-held StemoniX. More news on: Cancer Genetics, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Sonnet BioTherapeutics Holdings (NASDAQ: SONN ) +67%  on FDA nod for convalescent plasma. More news on: Sonnet BioTherapeutics Holdings, Inc., Liminal BioSciences Inc., ADMA Biologics, Inc., Stocks on the move, , Read more ...

Combined Company Positioned to Offer Best-in-Class and Innovative Drug Discovery Solutions RUTHERFORD, NJ and MAPLE GROVE, MN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), and StemoniX, Inc., today announced the entry into a ...

RUTHERFORD, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced yesterday financial and operating results for the quarter ended June 30, 2020. ...

The following healthcare companies have filed for mixed shelf offerings: More news on: Veru Inc., Cancer Genetics, Inc., Trevi Therapeutics, Inc., Healthcare stocks news, , Read more ...